Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012

被引:6
|
作者
Baviera, M. [1 ]
Avanzini, F. [1 ]
Marzona, I. [1 ]
Tettamanti, M. [2 ]
Vannini, T. [1 ]
Cortesi, L. [3 ]
Fortino, I. [4 ]
Bortolotti, A. [4 ]
Merlino, L. [4 ]
Trevisan, R. [5 ]
Roncaglioni, M. C. [1 ]
机构
[1] IRCCS, Ist Ric Farmacol Mario Negri, Lab Cardiovasc Prevent, Via Giuseppe La Masa 19, I-20156 Milan, Italy
[2] IRCCS, Ist Ric Farmacol Mario Negri, Lab Geriatr Epidemiol, Milan, Italy
[3] IRCCS, Ist Ric Farmacol Mario Negri, Lab Qual Assessment Geriatr Therapies & Serv, Milan, Italy
[4] Reg Hlth Minist, Milan, Italy
[5] Osped Riuniti Bergamo, Dept Internal Med, Diabetol Unit, Bergamo, Italy
关键词
Diabetes complications; Death; Antidiabetic drugs; Databases research; TRENDS; MELLITUS; DISEASE;
D O I
10.1016/j.numecd.2016.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: In contrast to the well-documented global prevalence of diabetes, much less is known about the epidemiology of cardiovascular (CV) complications in recent years. We describe the incidence of major CV events, deaths and drug prescribing patterns from 2002 to 2012 in subjects with (DM) or without diabetes mellitus (No DM). Methods and results: Subjects and outcomes were identified using linkable health administrative databases of Lombardy, a region in Northern Italy. A logistic regression model was used to compare myocardial infarction (MI), stroke, major amputation and death between DM and No DM in 2002 and 2012 and between the two index years in each population. The interaction between years and diabetes was introduced in the model. From 2002 to 2012 the incidence of major CV complications and death fell in both groups with a larger reduction among DM only for CV events: OR (95% CI) for the interaction 0.86 (0.79-0.93) for MI, 0.89 (0.82-0.96) for stroke, 0.78 (0.57-1.06) for major amputations. CV prevention drugs rose considerably from 2002 to 2012 particularly in DM and a switch towards safer antihyperglycemic drugs was also observed. Conclusions: Major CV complications and death declined from 2002 to 2012 in both DM and No DM. This might be due to a larger increase in prescriptions of CV drugs in DM and a relevant change toward recommended antihyperglycemic drugs. (C) 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:54 / 62
页数:9
相关论文
共 50 条
  • [1] Diabetes Incidence in Subjects with and without Cardiovascular Complications
    Johansen, Odd Erik
    Ofstad, Anne Pernille
    Sorensen, Monica
    Blaasaas, Karl G.
    Gullestad, Lars
    Birkeland, Kare I.
    [J]. DIABETES, 2009, 58 : A550 - A550
  • [2] Validation of attribution of reimbursed drug prescriptions in administrative databases in Northern Italy
    Villa, Marco
    Cocci, Alfredo
    Beduschi, Luciana
    Belloli, Andrea
    Mannino, Salvatore
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S103 - S103
  • [3] Apolipoprotein E Gene Variation in Pakistani Subjects with Type 2 Diabetes with and without Cardiovascular Complications
    Nadeem, Shehwar
    Maqbool, Tahir
    Qureshi, Javed Anver
    Altaf, Awais
    Naz, Sadia
    Azhar, Muzammal Mateen
    Ullah, Inam
    Shah, Tawaf Ali
    Qamar, Muhammad Usman
    Salamatullah, Ahmad Mohammad
    [J]. MEDICINA-LITHUANIA, 2024, 60 (06):
  • [4] Metformin: drug of choice for the prevention of type 2 diabetes and cardiovascular complications in high-risk subjects
    Standl, E
    [J]. DIABETES & METABOLISM, 2003, 29 (04) : S121 - S122
  • [5] Changes in antiepileptic drug prescriptions over a decade in childbearing women in Lombardy region, Italy
    Clavenna, Antonio
    Campi, Rita
    Putignano, Daria
    Fortino, Ida
    Bonati, Maurizio
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1152 - 1158
  • [6] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [7] Recent trends in cardiovascular complications among men and women with and without diabetes
    Booth, GL
    Kapral, MK
    Fung, K
    Tu, JV
    [J]. DIABETES CARE, 2006, 29 (01) : 32 - 37
  • [8] Cardiovascular complications in COVID-19 patients with or without diabetes mellitus
    Abe, Temidayo
    Egbuche, Obiora
    Igwe, Joseph
    Jegede, Opeyemi
    Wagle, Bivek
    Olanipekun, Titilope
    Onwuanyi, Anekwe
    [J]. ENDOCRINOLOGY DIABETES & METABOLISM, 2021, 4 (02)
  • [9] Predictors of Atherosclerotic Cardiovascular Disease Risk in Subjects With Diabetes With and Without Cardiovascular Disease: The ACCORD Study
    Wong, Nathan D.
    Zhao, Yanglu
    Bertoni, Alain
    Hlavacek, Patrick
    Tarasenko, Lisa
    Masseria, Cristina
    [J]. CIRCULATION, 2017, 136
  • [10] Drug prescribing during pregnancy in a central region of Italy, 2008-2012
    Martina Ventura
    Alice Maraschini
    Paola D’Aloja
    Ursula Kirchmayer
    Ilaria Lega
    Marina Davoli
    Serena Donati
    [J]. BMC Public Health, 18